scholarly journals The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

Eye ◽  
2002 ◽  
Vol 16 (6) ◽  
pp. 689-693 ◽  
Author(s):  
T A Chowdhury ◽  
D Hopkins ◽  
P M Dodson ◽  
G C Vafidis
Keyword(s):  
Serum Lipids ◽  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Diabetic Maculopathy ◽  
Lowering Therapy

scholarly journals Role of Colesevelam in Combination Lipid-Lowering Therapy

2013 ◽  
Vol 13 (5) ◽  
pp. 315-323 ◽  
Author(s):  
Michael R. Jones ◽  
Oliseyenum M. Nwose
Keyword(s):  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Lowering Therapy

scholarly journals The role of soluble fiber intake in patients under highly effective lipid-lowering therapy

2011 ◽  
Vol 10 (1) ◽  
Author(s):  
Silvia C Ramos ◽  
Francisco A Fonseca ◽  
Soraia H Kasmas ◽  
Flávio T Moreira ◽  
Tatiana Helfenstein ◽  
...  
Keyword(s):  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Fiber Intake ◽  
Soluble Fiber ◽  
Lowering Therapy ◽  
Highly Effective

Lipid-lowering therapy is associated with resolution of exudates in diabetic maculopathy

2006 ◽  
Vol 6 (4) ◽  
pp. 181-183
Author(s):  
Hiten G Sheth ◽  
Sher Aslam ◽  
Michael D Feher ◽  
Nigel Davies
Keyword(s):  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Diabetic Maculopathy ◽  
Lowering Therapy

The role of bempedoic acid in the management of dyslipidaemia

2021 ◽  
Vol 3 (12) ◽  
pp. 484-488
Author(s):  
Beverley Bostock
Keyword(s):  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Technology Appraisal ◽  
The United Kingdom ◽  
Lipid Lowering Drug ◽  
Lowering Therapy ◽  
Lowering Drug

Bempedoic acid is a new oral lipid-lowering therapy which has been licenced for use in the United Kingdom. It can be used alone, with a statin, or with other lipid-lowering therapies where the target level for low density lipoprotein has not been achieved with these therapies alone. Bempedoic acid with ezetimibe can be prescribed for people who are unable to tolerate statins. This combination has received NICE approval following a technology appraisal. This paper discusses the place for of bempedoic acid as a lipid lowering drug and consider the mode of action, licensed indications, adverse drug reactions and the NICE technology appraisal recommendations.

Role of Lipid Lowering Therapy and Renin Angiotensin Blockade in Outcomes of Patients With Atrial Fibrillation

2012 ◽  
Vol 109 (8) ◽  
pp. 1238
Author(s):  
Apurva O. Badheka ◽  
Tushar Tuliani ◽  
Ankit Rathod ◽  
Maithili Shenoy ◽  
Luis Afonso ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Renin Angiotensin ◽  
Lowering Therapy ◽  
Angiotensin Blockade
Sign in / Sign up

Export Citation Format

Share Document